Skip to main content

Month: February 2021

Cosmetic Surgery Market 2021 Size & Share | Market worth USD 66.96 billion with 3.6% CAGR by 2026

Pune, India, Feb. 03, 2021 (GLOBE NEWSWIRE) — The global cosmetic surgery market Share is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report. The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.Rising Emphasis on Reduced Post-surgical Interventions to Propel GrowthThe market consists of several prominent companies...

Continue reading

Danske Bank issues structured notes linked to S&P 500

Danske Bank issues structured notes linked to S&P 500On 4 February 2021, Danske Bank will issue USD 1,960,000 in index-linked notes linked to the performance of the index value of the S&P 500 Index. The notes are designated “DANSKE 0BTZ US Buffer 2022”, (ISIN: XS2289840782).The notes are issued at a price of 100. The notes do not pay interest.The notes are issued under Danske Bank’s EUR 5,000,000,000 Structured Note Programme dated 17 June 2021.For further information about the notes, please see the Final Terms attached to this announcement which together with the Base Prospectus specify the terms and conditions of the notes.Danske Bank A/SErkki Tapio Rusi, Global Head of Investment Solutions, tel. +358 (0) 10 513 8709 AttachmentsCompany announcement 03 Jan 2021Final Terms – DB 0BTZ SPX Buffer 2022 combined

Continue reading

Danske Bank udsteder obligationer knyttet til udviklingen i S&P 500

Danske Bank udsteder obligationer knyttet til udviklingen i S&P 500Danske Bank udsteder den 4. januar 2021 obligationer for i alt USD 1.960.000 nominelt, knyttet til udviklingen i aktieindekset S&P 500. Obligationerne benævnes “DANSKE 0BTZ US Buffer 2022”, (ISIN: XS2289840782).Obligationerne udstedes til kurs 100. Obligationerne betaler ikke rente.Obligationerne udstedes under Danske Banks EUR 5,000,000,000 Structured Note Programme af 17. juni 2020.For yderligere information henvises til Final Terms, der er vedlagt denne selskabsmeddelelse, der sammen med basisprospektet udgør vilkårene for obligationerne.Danske Bank A/SKontakt: Erkki Tapio Rusi, Global Head of Investment Solutions, tlf. +358 (0) 10 513 8709 Vedhæftede filerSelskabsmeddelelse 03 jan 2021Final Terms – DB 0BTZ SPX Buffer 2022 combined

Continue reading

Global Medical Marijuana Market 2021, Size & Share | Market Worth USD 178.95 Billion with 5.7% CAGR by 2026

Pune, India, Feb. 03, 2021 (GLOBE NEWSWIRE) — According to the report, Medical Marijuana market size is projected reach USD 26,920.4 million by 2026. Global Medical Marijuana market was USD 6,338.1 million in 2018 and is anticipated to exhibit a CAGR of 20.4% during the forecast period set between 2019 to 2026.Geographically, North America earned the maximum medical marijuana market share with a revenue of USD 5,994.9 million earned in 2018, that is anticipated to reach USD 24,578.3 million by the end of 2026.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-marijuana-market-102609Medicinal Properties of Cannabis to Propel GrowthThe increasing demand for legalization of medical cannabis across various states is a major medical marijuana market growth driver....

Continue reading

Infusion Pumps Market 2021 Size & Share | Market worth USD 16.09 Billion with 7.1% CAGR by 2026

Pune, India, Feb. 03, 2021 (GLOBE NEWSWIRE) — The global infusion Pump market size is predicted to reach USD 16.09 billion by 2026, exhibiting a CAGR of 7.1% during the forecast period. The increasing prevalence of chronic diseases will spur demand for infusion Pump in the forthcoming years. Moreover, the growing advancements in drug delivery systems will boost the infusion Pump market trends during the forecast period. The increasing adoption of advanced treatment techniques will have a positive impact on the infusion Pump market growth in the foreseeable future.The market in North America stood at USD 3.41 billion in 2018. The growth in region is attributed to higher diagnosis and treatment rates for diabetes coupled with high adoption of ambulatory infusion Pump. Moreover, favorable reimbursement policies will aid growth in the...

Continue reading

Private Placement Markets to Exit Private Real Estate Lending and Grow its CMBS Operations.

Steve Muehler, the Founder and Senior Managing Member of the Private Placement Markets stated that firm has ceased its Private Real Estate Loan Originations for its RREABC / CMFABC / CREABC Market and will convert all operations of those private markets into the Firm’s growing CMBS Operations. According to Steve Muehler, “the disruption caused by the COVID-19 pandemic is real, and is on-going, and falling into a more traditional form of lending in the residential and commercial real estate markets is prudent at times like these. This does not mean that lending opportunities for the right project, with the right seasoned developers in the right market does not exist….. infact we see opportunities in multifamily, office, industrial, and special types of properties that meet all the criteria for investment, but today you need all legs of...

Continue reading

Check Point Software Technologies Reports 2020 Fourth Quarter and Full Year Financial Results

SAN CARLOS, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the fourth quarter and full year ended December 31, 2020.Fourth Quarter 2020        Total Revenues: $564 million, a 4 percent increase year over yearDeferred Revenues: $1,482 million, a 7 percent increase year over yearGAAP Operating Income: $251 million, representing 45 percent of revenuesNon-GAAP Operating Income: $285 million, representing 51 percent of revenuesGAAP EPS: $1.95, a 6 percent increase year over yearNon-GAAP EPS: $2.17, a 7 percent increase year over yearFull Year 2020Total Revenues: $2,065 million, a 4 percent increase year over yearGAAP EPS: $5.96, a 10 percent increase year over yearNon-GAAP EPS: $6.78, an 11 percent increase year over year“We are pleased with our...

Continue reading

HONKARAKENNE INCREASES ITS PROFIT FORECAST FOR 2020

HONKARAKENNE OYJ Inside information 3 February 2021 at 10:30 a.m.HONKARAKENNE INCREASES ITS PROFIT FORECAST FOR 2020Honkarakenne estimates that in 2020 its revenue (net sales) will be higher and adjusted profit before taxes will be at the same level as in the previous year. The reason for the better-than-expected development is the higher-than-expected volume towards the end of the year and the growth of Russian exports.Honkarakenne’s updated outlook: In Honkarakenne’s view, in 2020 revenue (net sales) will increase from the previous year and adjusted profit before taxes will be on par with previous year.Honkarakenne’s previous outlook was as follows: Honkarakenne’s view is that revenue (net sales) in 2020 will be on par with previous year. Adjusted profit before taxes is however weaker than previous year.Honkarakenne...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.